Context The MEN1 syndrome is associated with parathyroid, pancreatic and pituitary
tumours and is caused by mutations in the MEN1 gene. In general, there is no genotype …

There have recently been reports of a limited number of laparoscopic procedures in patients
with clinically manifest hyperinsulinism. However, the precise role of laparoscopy remains …

Background Protein-truncating germline pathogenic variants in the N-and C-terminal exons
(2, 9, and 10) of the MEN1 gene may be associated with aggressive pancreatic …

Multiple endocrine neoplasia type 1 syndrome (MEN1) is a disease caused by mutations in
the MEN1 tumor suppressor gene leading to hyperparathyroidism, pituitary adenomas, and …

Multiple endocrine neoplasia type 1 (MEN1) is an inherited autosomal dominant disease
presenting with pancreatic neuroendocrine tumors (pNETs), parathyroid tumors, or pituitary …

Multiple endocrine neoplasia type 1 (MEN-1) is an interesting genetic syndrome of
polyendocrinopathies. Clinical knowledge about MEN-1 is essential as it appears to be …

Background The appropriate treatment for a sporadic endocrine tumour may be different
from those that present as part of the multiple endocrine neoplasia type 1 (MEN1) syndrome …

BACKGROUND: Pancreatoduodenal (PD) neoplasms represent the principal disease-
specific lethality in multiple endocrine neoplasia type 1 (MEN1). Potential oncologic benefits …

BACKGROUND: The purpose of this study is to describe outcomes of MEN-1 patients with
recurrence requiring completion pancreatectomy and duodenectomy after initial treatment of …

Background: Pancreatic neuroendocrine tumors (pNETs) are uncommon entities. pNETs are
often small, slow growing, clinically silent neoplasms. However, they have an almost …